Ginger Vieira Author Ginger Vieira has lived with type 1 diabetes and celiac disease since 1999, and fibromyalgia since 2014
Additionally, the company is asking for the associated lawsuits to be dismissed, under a 702 judgment, based on the adequacy of the FDA-approved product labeling and the lack of admissible expert testimony on general causation. This is a common defense tactic in mass litigation, like this MDL for Ozempic and other GLP-1 drugs
1,4 WeightWatchers has more extensive long-term research on its core programme, including an independent Lancet study showing modest weight-loss advantages over self-directed approaches
Tirzepatide is administered once weekly, and this frequency does not change as you increase your dose
385:503-515, DOI: 10.1056/NEJMoa2107519, 8/5/2021.